You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
February 2011
Br J Cardiol 2011;18:11-3
February 2011
Br J Cardiol 2011;18:24-7
Thiazolidinediones (glitazones) are a relatively new addition to the type 2 diabetes drug armoury, but they have caused considerable controversy since they were introduced into
September 2010
Br J Cardiol 2010;17:209
The National Institute for Health and Clinical Excellence (NICE) has published new guidance on the management of chronic heart failure. This updates and replaces the
September 2010
Br J Cardiol 2010;17:211-14
July 2010
Br J Cardiol 2010;17:163-5
Another trial stopped early because of benefit is EMPHASIS-HF (Eplerenone in Mild Patients Hospitalisation And SurvIval Study in Heart Failure) which looked at the aldosterone
May 2010
Br J Cardiol 2010;17:s10-s12
March 2010
Br J Cardiol 2010;17:67-8
March 2010
Br J Cardiol 2010;17:73–5
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
You need to be a member to download PDF's.
Sign up for free membership, or log in.
Find out more about our membership benefits